706 related articles for article (PubMed ID: 24315818)
41. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
42. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA‑10a enhances the metastatic potential of cervical cancer cells by targeting phosphatase and tensin homologue.
Zeng T; Li G
Mol Med Rep; 2014 Sep; 10(3):1377-82. PubMed ID: 25018014
[TBL] [Abstract][Full Text] [Related]
44. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
[TBL] [Abstract][Full Text] [Related]
46. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
47. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
48. p53 and microRNA-34 are suppressors of canonical Wnt signaling.
Kim NH; Kim HS; Kim NG; Lee I; Choi HS; Li XY; Kang SE; Cha SY; Ryu JK; Na JM; Park C; Kim K; Lee S; Gumbiner BM; Yook JI; Weiss SJ
Sci Signal; 2011 Nov; 4(197):ra71. PubMed ID: 22045851
[TBL] [Abstract][Full Text] [Related]
49. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
50. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
53. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
54. MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists.
Lv C; Li F; Li X; Tian Y; Zhang Y; Sheng X; Song Y; Meng Q; Yuan S; Luan L; Andl T; Feng X; Jiao B; Xu M; Plikus MV; Dai X; Lengner C; Cui W; Ren F; Shuai J; Millar SE; Yu Z
Nat Commun; 2017 Oct; 8(1):1036. PubMed ID: 29051494
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway.
Li Q; Shen K; Zhao Y; He X; Ma C; Wang L; Wang B; Liu J; Ma J
FEBS Lett; 2013 Jun; 587(12):1742-8. PubMed ID: 23587485
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.
Jiang Q; He M; Ma MT; Wu HZ; Yu ZJ; Guan S; Jiang LY; Wang Y; Zheng DD; Jin F; Wei MJ
Oncol Rep; 2016 Mar; 35(3):1425-32. PubMed ID: 26707142
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of adenomatous polyposis coli by microRNA-663 promotes odontogenic differentiation through activation of Wnt/beta-catenin signaling.
Kim JS; Park MG; Lee SA; Park SY; Kim HJ; Yu SK; Kim CS; Kim SG; Oh JS; You JS; Kim JS; Seo YS; Chun HS; Park JC; Kim DK
Biochem Biophys Res Commun; 2014 Apr; 446(4):894-900. PubMed ID: 24642258
[TBL] [Abstract][Full Text] [Related]
58. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
Li H; Bian C; Liao L; Li J; Zhao RC
Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
[TBL] [Abstract][Full Text] [Related]
59. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
60. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
